Stock MIR MEDMIRA INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News MedMira Inc.

Equities

MIR

CA58501R1029

Delayed Toronto S.E.
Other stock markets
 09:30:00 2024-04-25 am EDT 		5-day change 1st Jan Change
0.075 CAD 0.00% Intraday chart for MedMira Inc. -6.25% -31.82%
Apr. 02 MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024 CI
Mar. 27 Samsung Pay to stop working with Russia's Mir payment system from April 3 RE

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024
CI
Samsung Pay to stop working with Russia's Mir payment system from April 3
RE
MedMira Says Received Canadian Patent for its Quantitative Diagnostic System
MT
MedMira Brief: Says Received Canadian Patent for its Quantitative Diagnostic System
MT
MedMira's Fiscal Q1 Loss Widens, Revenue Drops
MT
MedMira Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023
CI
U.S. FDA Approves MedMira's Advanced Reveal G4 Rapid HIV-1/2 Antibody Test
CI
MedMira Inc. Reports Earnings Results for the Full Year Ended July 31, 2023
CI
Medmira Inc. Provides Update on Its Progress to Achieve Regulatory Approval in Canada and the USA for Its Infectious Disease Rapid Tests
CI
Canadian Investment Regulatory Organization Trade Resumption - MIR
AQ
Canadian Investment Regulatory Organization Trading Halt - MIR
AQ
MedMira's Fiscal Q3 Loss Widens, Revenue Falls
MT
MedMira Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023
CI
MedMira Falls Near 17% As Widens Q2 Net Loss YOY
MT
MedMira Widens Q2 Net Loss YOY
MT
MedMira Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023
CI
MedMira Inc. Provides an Update on Its Progress to Achieve Regulatory Approval in Canada for Its Reveal TP Antibody Test
CI
MedMira Enters into Partnership with Maternova for USA and Latin America
MT
MedMira enters into Partnership with Maternova for USA and Latin America
AQ
Maternova and MedMira Enter Distribution Agreement to Market Rapid Diagnostics for HIV, Syphilis and Hepatitis
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MIR Stock
  4. News MedMira Inc.